Detalhe da pesquisa
1.
Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine.
Eur J Neurol
; 31(2): e16106, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847221
2.
Migraine and cardiovascular disease: what cardiologists should know.
Eur Heart J
; 44(30): 2815-2828, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345664
3.
Migraine with and without aura in relation to the menstrual cycle and other hormonal milestones: A prospective cohort study.
Cephalalgia
; 43(6): 3331024231164322, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259230
4.
Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies.
Eur J Neurol
; 30(7): 2117-2121, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941533
5.
Visual hypersensitivity in patients treated with anti-calcitonin gene-related peptide (receptor) monoclonal antibodies.
Headache
; 63(7): 926-933, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358548
6.
Sex differences in migraine attack characteristics: A longitudinal E-diary study.
Headache
; 63(3): 333-341, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942410
7.
Revisiting dose-finding of monoclonal antibodies in migraine.
J Headache Pain
; 24(1): 69, 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296378
8.
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
J Headache Pain
; 24(1): 56, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208596
9.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
J Headache Pain
; 24(1): 128, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723437
10.
European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
J Headache Pain
; 24(1): 39, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038134
11.
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
J Headache Pain
; 24(1): 134, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814223
12.
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
J Headache Pain
; 24(1): 140, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884869
13.
Could erectile dysfunction be a side effect of CGRP inhibition? A case report.
Cephalalgia
; 42(3): 257-261, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404250
14.
Validation of diagnostic ICHD-3 criteria for menstrual migraine.
Cephalalgia
; 42(11-12): 1184-1193, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514214
15.
Serum CGRP in migraine patients using erenumab as preventive treatment.
J Headache Pain
; 23(1): 120, 2022 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089587
16.
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
J Headache Pain
; 23(1): 67, 2022 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690723
17.
Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine.
Curr Opin Neurol
; 34(3): 330-338, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852525
18.
Selective Phosphodiesterase 1 Inhibition Ameliorates Vascular Function, Reduces Inflammatory Response, and Lowers Blood Pressure in Aging Animals.
J Pharmacol Exp Ther
; 378(2): 173-183, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099502
19.
Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice.
Ann Neurol
; 88(4): 771-784, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583883
20.
Sex differences in prevalence of migraine trigger factors: A cross-sectional study.
Cephalalgia
; 41(6): 643-648, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203218